Modeling and simulation of the human δ opioid receptor

Protein Science

Volumn 13, Issue 8, 2004, Pages 1997-2008

  Aburi, Mahalaxmi ^a   Smith, Paul E ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

Activation mechanism; Agonist antagonist binding; Bovine rhodopsin; GPCR; Molecular dynamics

Indexed keywords

OPIATE AGONIST; OPIATE ANTAGONIST; RHODOPSIN; SIGMA OPIATE RECEPTOR;

ARTICLE; CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; HUMAN; LIPID BILAYER; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; SEQUENCE ALIGNMENT; SIMULATION;

ANIMALS; CATTLE; COMPUTER SIMULATION; HUMANS; MODELS, CHEMICAL; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, OPIOID, DELTA; RHODOPSIN; STRUCTURAL HOMOLOGY, PROTEIN;

BOVINAE;

EID: 3342939776     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.04720304     Document Type: Article

References (103)

1. Acharya, S. and Karnik, S.S. 1996. Modulation of GDP release from transducin by the conserved Glu134-Arg135 sequence in rhodopsin. J. Biol. Chem. 271: 25406-25411.
2. Akil, H., Watson, S.J., Young, E., Lewis, M.E., Khachaturian, H., and Walker, J.M. 1984. Endogenous opioids: Biology and function. Annu. Rev. Neurosci. 7: 223-255.
3. Alewijnse, A.E., Timmerman, H., Jacobs, E.H., Smit, M.J., Roovers, E., Cotecchia, S., and Leurs, R. 2000. The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H2 receptor. Mol. Pharmacol. 57: 890-898.
4. Alkorta, I. and Loew, G.H. 1996. A 3D model of the δ opioid receptor and ligand-receptor complexes. Protein Eng. 9: 573-583.
5. Arnis, S., Fahmy, K., Hofmann, K.P., and Sakmar, T.P. 1994. A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. J. Biol. Chem. 269: 23879-23881.
6. Baldwin, J.M. 1993. The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 12: 1693-1703.
7. Baldwin, J.M., Schertler, G.F.X., and Unger, V.M. 1997. An α-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. J. Mol. Biol. 272: 144-164.
8. Ballesteros, J.A. and Weinstein, H. 1995. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Meth. Neurosci. 25: 365-428.
9. Ballesteros, J.A., Kitanovic, S., Guarnieri, F., Davies, P., Fromme, B.J., Konvicka, K., Chi, L., Millar, R.P., Davidson, J.S., Weinstein, H., et al. 1998. Functional microdomains in G-protein coupled receptors. J. Biol. Chem. 273: 10445-10453.
10. Befort, K., Tabbara, D.K., Maigret, B., and Kieffer, B.L. 1996a. Role of aromatic transmembrane residues of the δ opioid receptor in ligand recognition. J. Biol. Chem. 271: 10161-10168.
11. Befort, K., Tabbara, L., Bausch, S., Chavkin, C., Evans, C., and Kieffer, B.L. 1996b. The conserved aspartate residue in the third putative transmembrane domain of the δ opioid receptor is not the anionic counterpart for cationic opiate binding but is a constituent of the receptor binding site. Mol. Pharmacol. 49: 216-223.
12. Befort, K., Zilliox, C., Filliol, D., Yue, S.Y., and Kieffer, B.L. 1999. Constitutive activation of the δ opioid receptor by mutations in transmembrane domains III and VII. J. Biol. Chem. 274: 18574-18581.
13. Berendsen, H.J.C., Postma, J.P.M., van Gunsteren, W.F., and Hermans, J. 1981. Interaction models for water in relation to protein hydration. In Intermolecular forces (ed. B. Pullman), pp. 331-342. D. Reidel Publishing, Dordrecht, The Netherlands.
14. Berendsen, H.J.C., Postma, J.P.M., van Gunsteren, W.F., DiNola, A., and Haak, J.R. 1984. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81: 3684-3690.
15. Bissantz, C. 2003. Conformational changes of G-protein coupled receptors during their activation by agonist binding. J. Recept. Signal Trans. 23: 123-153.
16. Bissantz, C., Bernard, P., Hilbert, M., and Rognan, D. 2003. Protein-based virtual screening of chemical databases, II: Are homology models of G-protein coupled receptors suitable targets? Proteins 50: 5-25.
17. Borders, C.L., Broadwater, J.A., Bekeny, P.A., Salmon, J.E., Lee, A.S., Eldridge, A.M., and Pett, V.B. 1994. A structural role for arginine in proteins: Multiple hydrogen bonds to backbone carbonyl oxygens. Protein Sci. 3: 541-548.
18. Brandt, W., Golbraikh, A., Tager, M., and Lendeckel, U. 1999. A molecular mechanism for the cleavage of a disulfide bond as the primary function of agonist binding to G-protein coupled receptors based on theoretical calculations supported by experiments. Eur. J. Biochem. 261: 89-97.
19. Breitwieser, G.E. 2004. G protein-coupled receptor oligomerisation. Circ. Res. 94: 17-27.
20. Burstein, E.S., Spalding, T.A., and Brann, M.R. 1998. The second intracellular loop of the m5 muscarinic receptor is the switch which enables G-protein coupling. J. Biol. Chem. 273: 24322-24327.
21. Chabre, M. 1985. Trigger and amplification mechanism in visual phototransduction. Ann. Rev. Biophys. Biophys. Chem. 14: 331-360.
22. Chan, A.S.L., Law, P.Y., Loh, H.H., Ho, P.N.N., Wu, W., Chan, J.S.C., and Wong, Y.H. 2003. The first and third intracellular loops together with carboxy terminal tail of the δ opioid receptor contribute toward functional interaction with G α16. J. Neurochem. 87: 697-708.
23. Chao, T.M., Perez, J.J., and Loew, G.H. 1996. Characterization of the bioactive form of linear antagonists at the ω-opioid receptor. Biopolymers 38: 759-768.
24. Chaturvedi, K., Christoffers, K.H., Singh, K., and Howells, R.D. 2000. Structure and regulation of opioid receptors. Biopolymers 55: 334-346.
25. Chen, Y., Mestek, A., Liu, J., Hurley, J.A., and Yu, L. 1993. Molecular cloning and functional expression of a m-opioid receptor from rat brain. Mol. Pharmacol. 44: 8-12.
26. Christopoulos, A. and Kenakin, T. 2002. G protein-coupled receptor allosterism and complexing. Pharmacol. Rev. 54: 323-374.
27. Cvejic, S. and Devi, L.A. 1997. Dimerization of the δ opioid receptor: Implication for a role in receptor internalization. J. Biol. Chem. 272: 26959-26964.
28. Decaillot, F.M., Befort, K., Filliol, D., Yue, S., Walker, P., and Kieffer, B.L. 2003. Opioid receptor random mutagenesis reveals a mechanism for G protein-coupled receptor activation. Nat. Struct. Biol. 10: 629-636.
29. Evans, C.J., Keith Jr., D.E., Morrison, H., Magendzo, K., and Edwards, R.H. 1992. Cloning of a δ opioid receptor by functional expression. Science 258: 1952-1955.
30. Fabian, G. 2001. Heterotrimeric G-proteins and their role in opioid receptor function. Acta Biologica Szegediensis 45: 13-21.
31. Fan, H. and Mark, A.E. 2004. Refinement of homology-based protein structures by molecular dynamics simulation techniques. Protein Sci. 13: 211-220.
32. Faraldo-Gomez, J.D., Smith, G.R., and Sansom, M.S.P. 2003. Molecular dynamics simulations of the bacterial outer membrane protein fluA: A comparative study of the ferrichrome-free and bound states. Biophys. J. 85: 1406-1420.
33. Feinberg, A.P., Creese, I., and Synder, S.H. 1976. The opiate receptor: A model explaining structure-activity relationships of agonists and antagonists. Proc. Natl. Acad. Sci. 73: 4215-4219.
34. Filizola, M., Carteni-Farina, M., and Perez, J.B. 1999a. Molecular modeling study of the differential ligand-receptor interaction at the μ, δ and κ opioid receptors. J. Comput. Aided Mol. Design 13: 397-407.
35. Filizola, M., Laakkonen, L., and Loew, G.H. 1999b. Three-dimensional modeling, ligand binding and activation studies of the cloned mouse δ, μ and κ opioid receptors. Protein Eng. 12: 927-942.
36. Filizola, M., Villar, H.O., and Loew, G.H. 2001. Molecular determinants of nonspecific recognition of δ, μ and κ opioid receptors. Bioorg. Med. Chem. 9: 69-76.
37. Fukuda, K., Kato, S., and Mori, K. 1995. Location of regions of the opioid receptor involved in selective agonist binding. J. Biol. Chem. 270: 6702-6709.
38. Genetics Computer Group. 1991. Program manual for the GCG package, version 7. Genetics Computer Group, Madison, WI.
39. Gether, U. 2000. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocrine Rev. 21: 90-113.
40. Gether, U., Ballesteros, J.A., Seifert, R., Sanders-Bush, E., Weinstein, H., and Kobilka, B.K. 1997. Structural instability of a constitutively active G-protein coupled receptor. J. Biol. Chem. 272: 2587-2590.
41. Gether, U., Asmar, F., Meinild, A.K., and Rasmussen, S.G.F. 2002. Structural basis for activation of G-protein coupled receptors. Pharmacol. Toxicol. 91: 304-312.
42. Giletto, A. and Pace, N. 1999. Buried, charged, non-ion-paired aspartic acid 76 contributes favorably to the conformational stability of ribonuclease T1. Biochemistry 38: 13379-13384.
43. Gilman, A.G. 1987. G proteins: Transducers or receptor-generated signals. Ann. Rev. Biochem. 56: 615-649.
44. Gioannini, T.L., Liu, Y.F., Park, Y.H., Hiller, J.M., and Simon, E.J. 1989. Evidence for the presence of disulfide bridges in opioid receptors essential for ligand binding: Possible role in receptor activation. J. Mol. Recog. 2: 44-48.
45. Grigorieff, N., Ceska, T.A., Downing, K.H., Baldwin, J.M., and Henderson, R. 1996. Electron-crystallographic refinement of the structure of bacteriorhodopsin. J. Mol. Biol. 259: 393-421.
46. Henderson, R., Baldwin, J.M., and Ceska, T.A. 1990. An atomic model for the structure of bacteriorhodopsin. J. Mol. Biol. 213: 899-929.
47. Horn, F., van der Wenden, E.M., Oliveira, L., IJzerman, A.P., and Vriend, G. 2000. Receptor coupling to G proteins: Is there a signal behind the sequence? Proteins 41: 448-459.
48. Horn, F., Bettler, E., Oliveira, L., Campagne, F., Cohen, F.E., and Vriend, G. 2003. GPCRDB information system for G protein-coupled receptors. Nucleic Acids Res. 31: 294-297.
49. Hosohata, Y., Varga, E., Stropova, D., Li, X., Knapp, R.J., Hruby, V.J., Rice, K.C., Nagase, H., Roeske, W., and Yamamura, H.I. 2001. Mutation W284L of the human δ opioid receptor reveals agonist specific receptor conformations for G protein activation. Life Sci. 68: 2233-2242.
50. Iadanza, M., Holtje, M., Ronsisvalle, G., and Holtje, H.D. 2002. κ-opioid receptor model in a phospholipid bilayer: Molecular dynamics simulations. J. Med. Chem. 45: 4843-4846.
51. Ji, T.H., Grossmann, M., and Ji, I. 1998. G protein-coupled receptors, I: Diversity of receptor-ligand interactions. J. Biol. Chem. 273: 17299-17302.
52. Karnik, S.S., Gogonea, C., Patil, S., Saad, Y., and Takezako, T. 2003. Activation of G protein-coupled receptors: A common molecular mechanism. Trends Endocrinol. Metab. 19: 431-437.
53. Kieffer, B.L., Befort, K., Gaveriaux-Ruff, C., and Hirth, C.G. 1992. The δ-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. 89: 12048-12052.
54. Kong, H., Raynor, K., Yasuda, K., Moe, S.T., Portoghese, P.S., Bell, G.I., and Reisine, T. 1993. A single residue, aspartic acid 95, in the δ opioid receptor specifies selective high affinity agonist binding. J. Biol. Chem. 268: 23055-23058.
55. Laskowski, R.A., MacArthur, M.W., Mass, D.S., and Thornton, J.M. 1993. PROCHECK: A program to check the steriochemical quality of protein structures. J. Appl. Crystallogr. 26: 283-291.
56. Lei, H. and Smith, P.E. 2003. The effects of internal water molecules on the structure and dynamics of chymotrypsin inhibitor 2. J. Phys. Chem. B 107: 1395-1402.
57. Li, X., Varga, E., Stropova, D., Zalewska, T., Malatynska, E., Knapp, R.J., Roeske, W., and Yamamura, H.I. 1996. δ Opioid receptor: The third extracellular loop determines naltrindole selectivity. Eur. J. Pharmacol. 300: R1-R2.
58. Lu, Z., Curtis, C.A., Jones, P.G., Pavia, J., and Hulme, E. 1997. The role of aspartate-arginine-tyrosine triad in the m1 muscarinic receptor: Mutations of aspartate 122 and tyrosine 124 decrease receptor expression but not abolish signalling. Mol. Pharmacol. 51: 234-241.
59. McFadyen, I., Metzer, T., Subramanian, G., Poda, G., Jorvig, E., and Ferguson, D.M. 2002. Molecular modeling of opioid receptor-ligand complexes. Progress Med. Chem. 40: 107-135.
60. Meng, F., Xie, G.X., Thompson, R.C., Mansour, A., Goldstein, A., Watson, S.J., and Akil, H. 1993. Cloning and pharmacological characterization of a rat κ opioid receptor. Proc. Natl. Acad. Sci. 90: 9954-9958.
61. Meng, F., Ueda, Y., Hoversten, M.T., Thompson, R.C., Taylor, L., Watson, S.J., and Akil H. 1996. Mapping the receptor domains critical for the ligand binding selectivity of δ opioid receptor. Eur. J. Pharmacol. 311: 285-292.
62. Metzer, T. and Ferguson, D.M. 1995. On the role of extracellular loops of opioid receptor in conferring ligand selectivity. FEBS Lett. 375: 1-4.
63. Morris, A.L., MacArthur, M.W., Hutchinson, E.G., and Thornton, J.M. 1992. Steriochemical quality of protein structure coordinates. Proteins 12: 345-364.
64. Mosberg, H.I. 1999. Complementarity of δ opioid ligand pharmacophore and receptor models. Biopolymers 51: 426-439.
65. Nayeem, A. and Scheraga, H.A. 1994. A statistical analysis of side-chain conformations in proteins: Comparison with ECEPP predictions. J. Protein Chem. 13: 283-296.
66. Palczewski, K., Kumasaka, T., Hori, T., Behnke, C.A., Motoshima, H., Fox, B.A., Trong, I.L., Teller, D.C., Okada, T., Stenkamp, R.E., et al. 2000. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289: 739-745.
67. Pepin, M., Yue, S.Y., Roberts, E., Wahlestedt, C., and Walker, P. 1997. Novel "restoration of function" mutagenesis strategy to identify amino acids of the δ opioid receptor involved in ligand binding. J. Biol. Chem. 272: 9260-9267.
68. Pogozheva, I.D., Lomize, A.L., and Mosberg, H.I. 1998. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints. Biophysical J. 75: 612-634.
69. Portoghese, P.S., Sultana, M., and Takemori, A.E. 1990. Design of peptidomimetic δ opioid receptor antagonists using the message-address concept. J. Med. Chem. 33: 1714-1720.
70. Quock, R.M., Burkey, T.H., Varga, E., Hosohata, Y., Hosohata, K., Cowell, S.M., Slate, C.A., Ehlert, F.J., Roeske, W.R., and Yamamura, H.I. 1999. The δ opioid receptor: Molecular pharmacology, signal transduction, and the determination of drug efficacy. Pharmacol. Rev. 51: 503-532.
71. Rapaka, R.S. and Porreca, F. 1991. Development of δ opioid peptides as non-addicting analgesics. Pharmacol. Res. 8: 1-8.
72. Rasmussen, S.G.F., Jensen, A.D., Liapakis, G., Ghanouni, P., Javitch, J.A., and Gether, U. 1999. Mutation of a highly conserved aspartic acid in the β2 adrenergic receptor: Constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6. Mol. Pharmacol. 56: 175-184.
73. Robinson, P.R., Cohen, G.B., Zhukovsky, E.A., and Oprian, D.D. 1992. Constitutively active mutants of rhodopsin. Neuron 9: 719-725.
74. Ryckaert, J.P., Ciccotti, G., and Berendsen, H.J.C. 1977. Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-Alkanes. J. Comput. Phys. 23: 327-341.
75. Salvadori, S., Balboni, G., Guerrini, R., Tomatis, R., Bianchi, C., Bryant, S.D., Cooper, P.S., and Lazarus, L.H. 1997. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary δ opioid antagonist activity. J. Med. Chem. 40: 3100-3108.
76. Scheer, A., Fanelli, F., Costa, T., and De Benedetti, P.G. 1997. The activation process of the α1B-adrenergic receptor: Potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc. Natl. Acad. Sci. 94: 808-813.
77. Scheer, A., Costa, T., Fanelli, F., De Benedetti, P.G., Mhaouty-Kodja, S., Abuin, L., Nenniger-Tosata, M., and Cotecchia, S. 2000. Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the α1b adrenergic receptor: Effects on receptor isomerisation and activation. Mol. Pharmacol. 57: 219-231.
78. Schertler, G.F.X., Villa, C., and Henderson, R. 1993. Projection structure of rhodopsin. Nature 362: 770-772.
79. Schiller, P.W., Nguyen, T.M.D., Weltrowska, G., Wilkes, B.C., Marsden, B.J., Lemieux, C., and Chung, N.N. 1992. Differential stereochemical requirements of δ vs. μ opioid receptors for ligand binding and signal transduction: Development of a class of potent and highly δ-selective peptide antagonists. Proc. Natl. Acad. Sci. 89: 11871-11875.
80. Schiller, P.W., Berezowska, I., Nguyen, T.M.D., Schmidt, R., Lemieux, C., Chung, N.N., Falcone-Hindley, M.L., Yao, W., Liu, J., Iwama, S., et al. 2000. Novel ligands lacking a positive charge for the δ and μ opioid receptors. J. Med. Chem. 43: 551-559.
81. Schiller, P.W., Weltrowska, G., Nguyen, T.M.D., Lemieux, C., Chung, N.N., and Lu, Y. 2003. Conversion of δ, κ and μ receptor selective opioid peptide agonists into δ, κ and μ selective antagonists. Life Sci. 73: 691-698.
82. Schonbrun, J., Wedemeyer, W.J., and Baker, D. 2002. Protein structure prediction in 2002. Curr. Opin. Struct. Biol. 12: 348-354.
83. Scott, W., Hunenberger, P.H., Tironi, I.G., Mark, A.E., Billeter, S.R., Fennen, J., Torda, A.E., Huber, T., Kruger, P., and van Gunsteren, W.F. 1999. The GROMOS biomolecular simulation program package. J. Phys. Chem. A 103: 3596-3607.
84. Shahrestanifar, M., Wang, W.W., and Howells, R.D. 1996. Studies on inhibition of μ and δ opioid receptor binding by dithiothreitol and N-ethylmaleimide. J. Biol. Chem. 271: 5505-5512.
85. Shenderovich, M.D., Liao, S., Qian, X., and Hruby, V.J. 2000. A three-dimensional model of the δ opioid pharmacophore: Comparative molecular modeling of peptide and nonpeptide ligands. Biopolymers 53: 565-580.
86. Simonds, W.F. 1988. The molecular basis of opioid receptor function. Endocrine Rev. 9: 200-212.
87. Smith, D.G. and Griffin, J.F. 1978. Conformation of leu enkephalin from X-ray diffraction: Features important for recognition at opiate receptor. Science 199: 1214-1216.
88. Smith, A.P. and Lee, N.M. 2003. Opioid receptor interactions: Local and non-local symmetric and asymmetric, physical and functional. Life Sci. 73: 1873-1893.
89. Smith, P.E. and van Gunsteren, W.F. 1994. Consistent dielectric properties of the simple point charge and extended simple point charge water models at 277 and 300K. J. Chem. Phys. 100: 3169-3174.
90. Stenkamp, R.E., Teller, D.C., and Palczewski, K. 2002. Crystal structure of rhodopsin: A G-protein-coupled receptor. ChemBioChem 3: 963-967.
91. Stocker, U., Spiegel, K., and van Gunsteren, W.F. 2000. On the similarity of properties in solution or in the crystalline state: A molecular dynamics study of hen lysosome. J. Biomol. NMR 18: 1-12.
92. Strader, C.D., Fong, T.M., Tota, M.R., Underwood, D., and Dixon, R.A.F. 1994. Structure and function of G protein-coupled receptors. Ann. Rev. Biochem. 63: 101-132.
93. Strahs, D. and Weinstein, H. 1997. Comparative modeling and molecular dynamics studies of the δ, κ and μ opioid receptors. Protein Eng. 10: 1019-1038.
94. Tironi, I.G., Sperb, R., Smith, P.E., and van Gunsteren, W.F. 1995. A generalized reaction field method for molecular dynamics simulations. J. Chem. Phys. 102: 5451-5459.
95. Unger, V.M., Hargrave, P.A., Baldwin, J.M., and Schertler, G.F.X. 1997. Arrangement of rhodopsin transmembrane α helices. Nature 389: 203-206.
96. Valiquette, M., Vu, H.K., Yue, S.Y., Wahlestedt, C., and Walker, P. 1996. Involvement of Trp-284, Val-296, Val-297 of the human δ opioid receptor in binding of δ selective ligands. J. Biol. Chem. 271: 18789-18796.
97. van Gunsteren, W.F. and Mark, A.E. 1998. Validation of molecular dynamics simulations. J. Chem. Phys. 108: 6109-6116.
98. Voordijk, S., Hansson, T., Hilvert, D., and van Gunsteren, W.F. 2000. Molecular dynamics simulations highlight mobile regions in proteins: A novel suggestion for converting a murine VH domain into a more tractable species. J. Mol. Biol. 300: 963-973.
99. Waldburger, C.D., Schildbach, J.F., and Sauer, R.T. 1995. Are buried salt bridges important for protein stability and conformational specificity? Nat. Struct. Biol. 2: 122-128.
100. Wess, J. 1998. Molecular basis of receptor/G-protein-coupling selectivity. Pharmacol. Ther. 80: 231-264.
101. Winn, P.J., Ludemann, S.K., Gauges, R., Lounnas, V., and Wade, R.C. 2002. Comparison of the dynamics of substrate access channels in three cytochrome P450s reveals different opening mechanisms and a novel functional role for a buried arginine. Proc. Natl. Acad. Sci. 99: 5361-5366.
102. Wong, S.K. 2002. G Protein selectivity is regulated by multiple intracellular regions of GPCRs. Neurosignals 12: 1-12.
103. Xu, W., Chen, C., Huang, P., Li, J., de Riel, J.K., Javitch, J.A., and Liu-Chen, L. 2000. The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the μ, δ, and κ opioid receptors. Biochemistry 39: 13904-13915.